Holen Sie sich die Stockscreener-App
3.53
10.31%
0.33
Handel nachbörslich:
3.65
0.12
+3.40%
Schlusskurs vom Vortag:
$3.20
Offen:
$3.25
24-Stunden-Volumen:
5.62M
Relative Volume:
0.64
Marktkapitalisierung:
$1.05B
Einnahmen:
$6.23M
Nettoeinkommen (Verlust:
$-95.90M
KGV:
-9.0513
EPS:
-0.39
Netto-Cashflow:
$-68.47M
1W Leistung:
+9.63%
1M Leistung:
-1.67%
6M Leistung:
+145.14%
1J Leistung:
+306.12%
1-Tages-Spanne:
$3.20
$3.55
1-Wochen-Bereich:
$2.99
$3.55
52-Wochen-Spanne:
$0.6513
$5.225
Precigen Inc Stock (PGEN) Company Profile
Firmenname
Precigen Inc
Sektor
Branche
Telefon
301-556-9900
Adresse
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Vergleichen Sie PGEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PGEN
Precigen Inc
|
3.53 | 1.13B | 6.23M | -95.90M | -68.47M | -0.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.90 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
470.27 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
576.42 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
815.61 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
316.15 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Precigen Inc Stock (PGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-15 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-03-22 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-05-23 | Eingeleitet | JP Morgan | Neutral |
| 2022-11-18 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-02-25 | Eingeleitet | Stifel | Buy |
| 2021-02-22 | Eingeleitet | Wells Fargo | Overweight |
| 2021-02-18 | Eingeleitet | B. Riley Securities | Buy |
| 2020-05-08 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Precigen Inc Aktie (PGEN) Neueste Nachrichten
Why Precigen Inc. stock appeals to dividend seekersJuly 2025 Pullbacks & High Yield Stock Recommendations - newser.com
How to integrate Precigen Inc. into portfolio analysis toolsTake Profit & Low Risk Entry Point Tips - newser.com
How Precigen Inc. stock performs in high volatility marketsJuly 2025 Market Mood & Daily Oversold Stock Bounce Ideas - newser.com
Will a bounce in Precigen Inc. offer an exitGap Up & Fast Entry Momentum Trade Alerts - newser.com
Institutional scanner results for Precigen Inc.July 2025 Fed Impact & Scalable Portfolio Growth Methods - newser.com
Precigen Says Drug for Rare Respiratory Disease Shows Durable Outcomes - MarketScreener
Precigen reports durable responses to RRP treatment in long-term data - Investing.com Nigeria
Precigen (PGEN) Showcases Promising Results for PAPZIMEOS in Tre - GuruFocus
Precigen Announces Long-Term Follow-Up Results Highlighting Ongoing Durable Complete Responses after Treatment with PAPZIMEOS, the First and Only FDA-approved Therapy for Adults with Recurrent Respiratory Papillomatosis - Yahoo Finance
Using flow based indicators on Precigen Inc.Market Volume Summary & Free Technical Pattern Based Buy Signals - newser.com
Analyzing recovery setups for Precigen Inc. investorsWeekly Stock Summary & Free Weekly Chart Analysis and Trade Guides - newser.com
Weiss Ratings Reaffirms Sell (D-) Rating for Precigen (NASDAQ:PGEN) - MarketBeat
How to monitor Precigen Inc. with trend dashboardsJuly 2025 Intraday Action & AI Enhanced Market Trend Forecasts - newser.com
Precigen, Inc. (PGEN) Stock Analysis: A Biotech Gem With 158% Upside Potential - DirectorsTalk Interviews
Will Precigen Inc. stock deliver long term returns2025 Analyst Calls & Consistent Profit Trade Alerts - newser.com
Why Precigen Inc. stock is seen as undervaluedJuly 2025 Catalysts & Low Risk Growth Stock Ideas - newser.com
Will Precigen Inc. stock deliver consistent dividendsMarket Trend Review & Low Drawdown Trading Techniques - newser.com
Precigen, Inc. (NASDAQ:PGEN) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Precigen (NASDAQ:PGEN) Trading 5.6% HigherStill a Buy? - MarketBeat
Chart based analysis of Precigen Inc. trends2025 Breakouts & Breakdowns & Verified Momentum Stock Alerts - newser.com
Is Precigen Inc. stock ready for a breakoutJuly 2025 Highlights & AI Forecast Swing Trade Picks - newser.com
Volatility clustering patterns for Precigen Inc.July 2025 Patterns & Free Community Consensus Stock Picks - newser.com
Critical Analysis: Precigen (NASDAQ:PGEN) and Entera Bio (NASDAQ:ENTX) - Defense World
Have Precigen Insiders Been Selling Stock? - 富途牛牛
Precigen, Inc. (PGEN) Stock Analysis: A 147.75% Upside Beckons Biotech Investors - DirectorsTalk Interviews
What machine learning models say about Precigen Inc.July 2025 Weekly Recap & Fast Entry and Exit Trade Plans - newser.com
These 2 Healthcare Stocks More Than Doubled Recently and Could Soar Higher, According to Wall Street Analysts - MSN
Insider Sell: Jeffrey Kindler Sells 174,360 Shares of Precigen I - GuruFocus
Precigen (NASDAQ:PGEN) Director Sells $243,082.80 in Stock - MarketBeat
Jeffrey Kindler Sells 106,837 Shares of Precigen (NASDAQ:PGEN) Stock - MarketBeat
Precigen Signs a Credit Facility Agreement Worth $125 Million to Support PAPZIMEOS - MSN
Insider Buying: Phil Tennant Acquires Shares of Precigen Inc (PG - GuruFocus
Precigen (NASDAQ:PGEN) Director Randal Kirk Sells 1,809,667 Shares - MarketBeat
Finanzdaten der Precigen Inc-Aktie (PGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Precigen Inc-Aktie (PGEN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| KINDLER JEFFREY B | Director |
Sep 29 '25 |
Sale |
3.60 |
67,523 |
243,083 |
452,907 |
| KIRK RANDAL J | Director |
Sep 30 '25 |
Sale |
3.41 |
1,809,667 |
6,170,964 |
14,597,161 |
4.09%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):